Title  | Date  | Price  |
|---|
Kidneys and Genito-Urinary System Urinary Incontinence Therapy Area Pipeline Report Urinary Incontinence
| Sep 2009 |
£920 |
Metabolic Endocrinology Obesity Therapy Area Pipeline Report Obesity
| Sep 2009 |
£920 |
Metabolic Endocrinology Type I Diabetes Therapy Area Pipeline Report Type I Diabetes
| Sep 2009 |
£920 |
Ophthalmology and Optometry Conjunctivitis Therapy Area Pipeline Report Conjunctivitis
| Sep 2009 |
£920 |
Metabolic Endocrinology Cachexia Therapy Area Pipeline Report Cachexia
| Sep 2009 |
£920 |
Metabolic Endocrinology Diabetic Neuropathy Therapy Area Pipeline Report Diabetic Neuropathy
| Sep 2009 |
£920 |
Metabolic Endocrinology Hypercalcemia Therapy Area Pipeline Report Hypercalcemia
| Sep 2009 |
£920 |
Metabolic Endocrinology Hormone Replacement Therapy Therapy Area Pipeline Report Hormone Replacement Therapy
| Sep 2009 |
£920 |
Metabolic Endocrinology Growth Hormone Deficiency Therapy Area Pipeline Report Growth Hormone Deficiency
| Sep 2009 |
£920 |
Musculo-Skeletal-Disorders Paget's Disease Therapy Area Pipeline Report Paget's Disease
| Sep 2009 |
£920 |
Musculo-Skeletal-Disorders Osteoporosis Therapy Area Pipeline Report Osteoporosis
| Sep 2009 |
£920 |
Kidneys and Genito-Urinary System Overactive Bladder Therapy Area Pipeline Report Overactive Bladder
| Sep 2009 |
£920 |
Substance Abuse Poisoning Therapy Area Pipeline Report Poisoning
| Sep 2009 |
£920 |
Central Nervous System Dementia Therapy Area Pipeline Report Dementia
| Sep 2009 |
£920 |
Infections Influenza Therapy Area Pipeline Report Influenza
| Sep 2009 |
£920 |
Metabolic Endocrinology Type II Diabetes Therapy Area Pipeline Report Type II Diabetes
| Sep 2009 |
£920 |
Musculo-Skeletal-Disorders Gout Therapy Area Pipeline Report Gout
| Sep 2009 |
£910 |
Musculo-Skeletal-Disorders Osteoarthritis Therapy Area Pipeline Report Osteoarthritis
| Sep 2009 |
£920 |
Musculo-Skeletal-Disorders Muscle Pain Therapy Area Pipeline Report Muscle Pain
| Sep 2009 |
£920 |
Central Nervous System Myasthenia Gravis Therapy Area Pipeline Report Myasthenia Gravis
| Sep 2009 |
£920 |
Metabolic Endocrinology Hypogonadism Therapy Area Pipeline Report Hypogonadism
| Sep 2009 |
£920 |
Metabolic Endocrinology Hypocalcemia Therapy Area Pipeline Report Hypocalcemia
| Sep 2009 |
£920 |
Ophthalmology and Optometry Eye Infections Therapy Area Pipeline Report Eye Infections
| Sep 2009 |
£920 |
Substance Abuse Opium Addiction Therapy Area Pipeline Report Opium Addiction
| Sep 2009 |
£920 |
Respiratory and Pulmonary System Pulmonary Hypertension Therapy Area Pipeline Report Pulmonary Hypertension
| Sep 2009 |
£920 |
Respiratory and Pulmonary System Bronchitis Therapy Area Pipeline Report Bronchitis
| Sep 2009 |
£920 |
Ophthalmology and Optometry Glaucoma Therapy Area Pipeline Report Glaucoma
| Sep 2009 |
£920 |
Respiratory and Pulmonary System Respiratory Tract Infections Therapy Area Pipeline Report Respiratory Tract Infections
| Sep 2009 |
£920 |
Respiratory and Pulmonary System Asthma Therapy Area Pipeline Report Asthma
| Sep 2009 |
£920 |
Ophthalmology and Optometry Ocular Inflammation Therapy Area Pipeline Report Ocular Inflammation
| Sep 2009 |
£920 |
Infections AIDS HIV Therapy Area Pipeline Report AIDS
| Sep 2009 |
£920 |
Respiratory and Pulmonary System Pulmonary Fibrosis Therapy Area Pipeline Report Pulmonary Fibrosis
| Sep 2009 |
£920 |
Respiratory and Pulmonary System Nasal congestion Therapy Area Pipeline Report Nasal congestion
| Sep 2009 |
£920 |
Respiratory and Pulmonary System Bronchospasm Therapy Area Pipeline Report Bronchospasm
| Sep 2009 |
£920 |
Ophthalmology and Optometry Macular Degeneration Therapy Area Pipeline Report Macular Degeneration
| Sep 2009 |
£920 |
Ophthalmology and Optometry Dry Eye Syndrome Therapy Area Pipeline Report Dry Eye Syndrome
| Sep 2009 |
£920 |
Respiratory and Pulmonary System Chronic Obstructive Pulmonary Disease Therapy Area Pipeline Report Chronic Obstructive Pulmonary Disease
| Sep 2009 |
£920 |
Substance Abuse Antidote Therapy Area Pipeline Report Antidote
| Sep 2009 |
£920 |
Respiratory and Pulmonary System Cystic Fibrosis Therapy Area Pipeline Report Cystic Fibrosis
| Sep 2009 |
£920 |
Respiratory and Pulmonary System Cough Therapy Area Pipeline Report Cough
| Sep 2009 |
£920 |
Substance Abuse Alcoholism Therapy Area Pipeline Report Alcoholism
| Sep 2009 |
£920 |
Ophthalmology and Optometry Diabetic Retinopathy Therapy Area Pipeline Report Diabetic Retinopathy
| Sep 2009 |
£920 |
Metabolic Endocrinology Vitamin Deficiency Therapy Area Pipeline Report Vitamin Deficiency
| Sep 2009 |
£920 |
Infections Diphtheria Therapy Area Pipeline Report Diphtheria
| Sep 2009 |
£920 |
Infections Onychomycosis Therapy Area Pipeline Report Onychomycosis
| Sep 2009 |
£920 |
Infections Fever Therapy Area Pipeline Report Fever
| Sep 2009 |
£920 |
Infections Fungal Infections or Candidiasis Therapy Area Pipeline Report Fungal Infections or Candidiasis
| Sep 2009 |
£920 |
Women's Health Vaginal Infections Therapy Area Pipeline Report Vaginal Infections
| Sep 2009 |
£920 |
Women's Health Postmenopausal Osteoporosis Therapy Area Pipeline Report Postmenopausal Osteoporosis
| Sep 2009 |
£920 |
Women's Health Infertility Therapy Area Pipeline Report Infertility
| Sep 2009 |
£920 |
Women's Health Labor and Delivery Therapy Area Pipeline Report Labor and Delivery
| Sep 2009 |
£920 |
Women's Health Menopausal Symptoms Therapy Area Pipeline Report Menopausal Symptoms
| Sep 2009 |
£920 |
Infections Helminthic Infestations Therapy Area Pipeline Report Helminthic Infestations
| Sep 2009 |
£920 |
Infections Hepatitis B Therapy Area Pipeline Report Hepatitis B
| Sep 2009 |
£920 |
Central Nervous System Pain Therapy Area Pipeline Report Pain
| Sep 2009 |
£920 |
Central Nervous System Migraine Therapy Area Pipeline Report Migraine
| Sep 2009 |
£920 |
Central Nervous System Multiple Sclerosis Therapy Area Pipeline Report Multiple Sclerosis
| Sep 2009 |
£920 |
Central Nervous System Insomnia or Sleep Disorders Therapy Area Pipeline Report Insomnia or Sleep Disorders
| Sep 2009 |
£920 |
Central Nervous System Huntington Disease Therapy Area Pipeline Report Huntington Disease
| Sep 2009 |
£920 |
Forecast Insight: Top 20 Cancer Therapy Brands Targeted therapies will drive market growth in the wake of the cytotoxic and antihormonal patent cliff Healthcare
| Sep 2009 |
£9,270 |
Cardiovascular and Circulatory System Peripheral Vascular Disease Therapy Area Pipeline Report Peripheral Vascular Disease
| Sep 2009 |
£920 |
Central Nervous System Headache Therapy Area Pipeline Report Headache
| Sep 2009 |
£920 |
Women's Health Female Sexual Dysfunction Therapy Area Pipeline Report Female Sexual Dysfunction
| Sep 2009 |
£920 |
Infections Ear Infections Therapy Area Pipeline Report Ear Infections
| Sep 2009 |
£920 |
Infections Throat Infection Therapy Area Pipeline Report Throat Infection
| Sep 2009 |
£920 |
Infections Tuberculosis Therapy Area Pipeline Report Tuberculosis
| Sep 2009 |
£920 |
Infections Urinary Tract Infections Therapy Area Pipeline Report Urinary Tract Infections
| Sep 2009 |
£920 |
Infections Viral Infections Therapy Area Pipeline Report Viral Infections
| Sep 2009 |
£920 |
Infections Tetanus Therapy Area Pipeline Report Tetanus
| Sep 2009 |
£920 |
Infections Staphylococcal Infections Therapy Area Pipeline Report Staphylococcal Infections
| Sep 2009 |
£920 |
Infections Pneumonia Therapy Area Pipeline Report Pneumonia
| Sep 2009 |
£920 |
Infections Sepsis Therapy Area Pipeline Report Sepsis
| Sep 2009 |
£920 |
Women's Health Endometriosis Therapy Area Pipeline Report Endometriosis
| Sep 2009 |
£920 |
Kidneys and Genito-Urinary System Benign Prostatic Hyperplasia Therapy Area Pipeline Report Benign Prostatic Hyperplasia
| Sep 2009 |
£920 |
Infections Skin and Soft Tissue Infections Therapy Area Pipeline Report Skin and Soft Tissue Infections
| Sep 2009 |
£920 |
Women's Health Abnormal Uterine Bleeding Therapy Area Pipeline Report Abnormal Uterine Bleeding
| Sep 2009 |
£920 |
Women's Health Contraception Therapy Area Pipeline Report Contraception
| Sep 2009 |
£920 |
Women's Health Dysmenorrhea Therapy Area Pipeline Report Dysmenorrhea
| Sep 2009 |
£920 |
Kidneys and Genito-Urinary System Diabetic Nephropathy Therapy Area Pipeline Report Diabetic Nephropathy
| Sep 2009 |
£920 |
Substance Abuse Smoking Cessation Therapy Area Pipeline Report Smoking Cessation
| Sep 2009 |
£920 |
Infections Hepatitis C Therapy Area Pipeline Report Hepatitis C
| Sep 2009 |
£920 |
Kidneys and Genito-Urinary System Erectile Dysfunction Therapy Area Pipeline Report Erectile Dysfunction
| Sep 2009 |
£920 |
Ophthalmology and Optometry Ocular Hypertension Therapy Area Pipeline Report Ocular Hypertension
| Sep 2009 |
£920 |
Infections Hepatitis Therapy Area Pipeline Report Hepatitis
| Sep 2009 |
£920 |
China Vaccine Industry Report, 2008-2009
| Aug 2009 |
£900 |
Competitor Analysis: Targeted Therapy of Hepatitis C
| Aug 2009 |
£445 |
Monoclonal Antibody Therapeutics 2009-2024
| Aug 2009 |
£1,499 |
Global Biometric Forecast to 2012
| Aug 2009 |
£1,200 |
The U.S. Biochip & Equipment Market & Business - 2003 Edition Technology Trends, Market & Business Trends, Sales, and Distribution
| Jul 2009 |
£660 |
The Exploding RNAi Market & Future Direction Translating the Genome into a Large Market by 2009
| Jul 2009 |
£855 |
Worldwide Market Research Nanotechnology-based Product Market and Business Opportunities - Current & Future Outlook
| Jul 2009 |
£1,520 |
Lung Cancer Therapeutics
| Jul 2009 |
£2,375 |
Brachytherapy
| Jul 2009 |
£2,375 |
ASCO 2009: Significant Developments in Context
| Jul 2009 |
£595 |
U.S. CRO Markets - Key Therapeutic Areas
| Jul 2009 |
£3,605 |
Forecast Insight: Antihypertensives New fixed dose combinations unable to stem the tide of patent expiries
| Jul 2009 |
£9,140 |
Stakeholder Opinions: Skin and soft tissue infections
| Jul 2009 |
£2,285 |
Obesity Market Forecast
| Jul 2009 |
£9,140 |
Delivering RNAi-Based Therapeutics & Diagnostics Challenges & Opportunities
| Jul 2009 |
£945 |
Autoimmune Disease Therapeutics
| Jul 2009 |
£2,375 |